NetworkNewsBreaks – Pressure BioSciences Inc. (P
Post# of 1354
(Total Views: 151)
Posted On: 09/28/2018 6:22:06 PM
NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) Strengthens IP Portfolio
Pressure BioSciences (OTCQB: PBIO) was recently granted another patent to add to its intellectual property (“IP”) portfolio regarding its development of an automated “hands-free” sample handling for the next generation of the company’s high-pressure sample preparation platform systems. A recent article discussing the company’s technology reads, “The global sample preparation market is projected to reach $8.2 billion by 2024, according to a report by TransparencyMarketResearch (http://nnw.fm/u1I4Y). Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument system, which can be used to exquisitely control the sample preparation process. Based on the company’s patented and enabling pressure cycling technology (PCT) platform, over 300 Barocycler systems have been installed in approximately 200 academic, government, pharmaceutical and biotech research laboratories worldwide. These laboratories use the PCT instrument system for multiple applications, including the preparation of samples for biomarker and target discovery, soil & plant biology, anti-bioterror and forensics studies. There are over 100 independent scientific publications highlighting the advantages of the PCT system in such studies, many from worldwide key opinion leaders.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Pressure BioSciences (OTCQB: PBIO) was recently granted another patent to add to its intellectual property (“IP”) portfolio regarding its development of an automated “hands-free” sample handling for the next generation of the company’s high-pressure sample preparation platform systems. A recent article discussing the company’s technology reads, “The global sample preparation market is projected to reach $8.2 billion by 2024, according to a report by TransparencyMarketResearch (http://nnw.fm/u1I4Y). Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument system, which can be used to exquisitely control the sample preparation process. Based on the company’s patented and enabling pressure cycling technology (PCT) platform, over 300 Barocycler systems have been installed in approximately 200 academic, government, pharmaceutical and biotech research laboratories worldwide. These laboratories use the PCT instrument system for multiple applications, including the preparation of samples for biomarker and target discovery, soil & plant biology, anti-bioterror and forensics studies. There are over 100 independent scientific publications highlighting the advantages of the PCT system in such studies, many from worldwide key opinion leaders.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Pressure Biosciences (PBIO) Stock Research Links
Scroll down for more posts ▼